特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
473405

医用画像分析ソフトウェアの世界市場:考察、機会、分析、市場シェア、将来予測

Global Medical Imaging Analysis Software Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版日: | 発行: Occams Business Research & Consulting Pvt. Ltd. | ページ情報: 英文 140 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
医用画像分析ソフトウェアの世界市場:考察、機会、分析、市場シェア、将来予測
出版日: 2017年03月10日
発行: Occams Business Research & Consulting Pvt. Ltd.
ページ情報: 英文 140 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、医療画像分析用ソフトウェアの世界市場について分析し、技術・市場の概略や最新動向、主な市場促進・阻害要因、市場の機会・課題、ソフトウェア別・画像の種類別・モダリティ別・エンドユーザー別・用途別および地域別の市場動向予測 (過去3年間・今後7年間分)、競合情勢、戦略提言、市場発展の方向性、主要企業のプロファイル・戦略などを調査しております。

第1章 イントロダクション

第2章 市場概要

  • 医用画像分析ソフトウェア市場:発展と遷移
  • 産業構造
  • 製造工程
  • 規制枠組み
  • 市場全体の分析
  • 市場推計分析
  • 戦略分析
    • 投資/導入モデル
    • 全方位的な産業分析
    • ポーターのファイブフォース分析
    • シーソー分析
    • 消費者分析と主な購入基準
    • ギャップ分析
  • 市場競争分析
    • 市場シェア分析
    • 主要企業の分析
  • 戦略的提言と主な結論
    • 各地域での市場機会
    • 新規分野での市場機会
    • 急成長市場での投資機会

第3章 市場の決定要因

  • 市場促進要因とその影響
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第4章 市場区分

  • 医用画像分析ソフトウェア市場:ソフトウェア別
    • 市場の定義と範囲
    • 意思決定支援データベースおよび推計手法
    • 市場間の比較分析
    • 市場機会マトリックス
    • 市場区分:ソフトウェア別 (金額ベース、通算10年間分)
      • 一体型ソフトウェア
      • 独立型 (スタンドアロン) ソフトウェア
  • 医用画像分析ソフトウェア市場:画像別
    • 市場区分:画像の種類別 (金額ベース、通算10年間分)
      • 2Dイメージング (二次元画像)
      • 3Dイメージング (三次元画像)
      • 4Dイメージング (四次元画像)
  • 医用画像分析ソフトウェア市場:モダリティ別
    • 市場区分:モダリティ別 (金額ベース、通算10年間分)
      • 断層診断 (CT)
      • 超音波画像
      • 核画像
      • 併用方式 (複合モダリティ)
  • 医用画像分析ソフトウェア市場:エンドユーザー別
    • 市場区分:エンドユーザー別 (金額ベース、通算10年間分)
      • 病院
      • 診断センター
      • 研究センター
  • 医用画像分析ソフトウェア市場:用途別
    • 市場区分:用途別 (金額ベース、通算10年間分)
      • 眼科
      • 歯科
      • 神経科
      • 循環器科
      • 腫瘍科
      • 肥満症・婦人科
      • マンモグラフィー
      • 泌尿器科・腎臓病

第5章 競争環境

  • 主な戦略
    • 企業合併・買収 (M&A) の一覧
    • 合弁事業 (JV) の一覧
    • 製品発売の一覧
    • 事業提携の一覧
  • 上位10社の分析

第6章 地域別分析

  • 意思決定支援データベースおよび推計手法
  • 市場間の比較分析
  • 市場機会マトリックス
  • 市場区分:地域別 (金額ベース、通算10年間分)
    • 北米市場
    • 欧州市場
    • アジア太平洋地域市場
    • 他の国々 (RoW)

第7章 企業プロファイル

目次
Product Code: HHE-4600317

Global Medical Imaging Analysis Software Market is anticipated to reach US $3,335.3 million with an attractive CAGR of 8.2% during 2016 - 2022. The major drivers which are enhancing the global medical imaging analysis software market are due to rising due to rapid increase in demand for technically progression market for imaging devices, a lot of investment in medical imaging technologies, increasing geriatric population, due to increasing huge number of enduring research activities and growth in the number of new and advanced products being launched in developing Asian countries. Apart from this, some of the factors which are hampering the market are absence of technical and skilled professionals and due to increasing hacking concerns.

The medical imaging analysis software market is segmented on the basis of software, image, modality, application and end-user. According to software segment, the market is further segmented such as integrated software and standalone software. On the basis of image segment, the market is further subdivided into 2D imaging, 3D imaging, and 4D imaging. On the basis of modality segment, the market is further divided into tomography (Computed Tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and single-photon emission tomography (SPECT)), ultrasound imaging, radiographic imaging, and combined modalities. On the basis, of application segment, the market is further subdivided into orthopedic application, dental applications, neurology, cardiology application, oncology applications, oncology applications, mammography applications and urology and nephrology applications. On the basis of end-user segment, the market is further subdivided into hospitals, diagnostic centers, and research centers.

On the basis of geography, the global medical imaging analysis software market is segmented into four major regions such as North America, APAC, Europe and ROW. Currently, North America is accounted to be the largest market share nearly 35% for medical image analysis software due to huge demand for post-diagnostic treatment and better detection. Asia Pacific is a forthcoming market because of rise in per capita income and technological advancements in diagnostic technology. Asia Pacific is projected to be growing upward at the fastest CAGR of over 9.5% during the prediction period due to the increasing saturation of the medical imaging systems in fast developing economies of the Asia Pacific region, such as India and China. Along with this, there are many of the further driving factors that are promoting overall growth of the market such as high R&D intensity by the major market players, investments in the healthcare industry.

There are many key manufacturing companies which are engaged in Esaote S.p.A (Italy), Agfa healthcare (Belgium), Carestream Health, Inc. (U.S.), Aquilab (France), GE Healthcare (U.K.), MIM Software Inc. (U.S.), Philips Healthcare (Netherlands), Merge Healthcare, Inc. (U.S.), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan). One of the top most manufacturing company 'Philips Healthcare" has launched a new advanced diagnostic equipment which has been developed and designed at its one of the two R&D centers which one of them in India (Pune). One of the two products exposed, which are the mobile diagnost opta, one of them, digital X-Ray system is for limited spaces like rigorous care units and operations theatres. Other than that, BV Vectra is a mobile C-arm system devoted to orthopaedic surgical procedures.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.6. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. MARKET SHARE ANALYSIS
    • 2.8.2. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. TECHNOLOGICAL DEVELOPMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE
    • 3.1.2. INCREASING PUBLIC AND PRIVATE SECTOR INVESTMENTS IN THE MEDICAL IMAGING MARKET
    • 3.1.3. RISING APPLICATIONS OF COMPUTER-AIDED DIAGNOSIS (CAD)
    • 3.1.4. GROWING USAGE OF IMAGING EQUIPMENT
    • 3.1.5. GROWING INCIDENCES OF CHRONIC DISEASES
    • 3.1.6. INCREASE IN FLEXIBILITY
    • 3.1.7. RAPID GROWTH IN AGING POPULATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. ABSENCE OF SKILLED PROFESSIONALS
    • 3.2.2. INCREASING SOFTWARE HACKING CONCERNS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. CLOUD-BASED IMAGE ANALYSIS SOLUTIONS
    • 3.3.2. EXPANSION IN DEVELOPING MARKETS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. MARKET PENETRATION OF STANDALONE SOFTWARE VENDORS
    • 3.4.2. HIGH COST OF SOFTWARE

4. MARKET SEGMENTATION

  • 4.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION BY SOFTWARE 2014-2023 ($ MILLION)
      • 4.1.5.1. INTEGRATED SOFTWARE
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. APPLICATION
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.1.5.1.6. KEY CONCLUSIONS
      • 4.1.5.2. STANDALONE SOFTWARE
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. APPLICATION
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.1.5.2.6. KEY CONCLUSIONS
  • 4.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION BY IMAGE 2014-2023 ($ MILLION)
      • 4.2.5.1. 2D IMAGING
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. APPLICATION
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.1.6. KEY CONCLUSIONS
      • 4.2.5.2. 3D IMAGING
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. APPLICATION
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.2.6. KEY CONCLUSIONS
      • 4.2.5.3. 4D IMAGING
        • 4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.3. APPLICATION
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.3.6. KEY CONCLUSIONS
  • 4.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION BY MODALITY 2014-2023 ($ MILLION)
      • 4.3.5.1. TOMOGRAPHY
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. APPLICATION
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.1.6. KEY CONCLUSIONS
      • 4.3.5.2. ULTRASOUND IMAGING
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. APPLICATION
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.2.6. KEY CONCLUSIONS
      • 4.3.5.3. RADIOGRAPHIC IMAGING
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. APPLICATION
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.3.6. KEY CONCLUSIONS
      • 4.3.5.4. COMBINED MODALITIES
        • 4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.3. APPLICATION
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.4.6. KEY CONCLUSIONS
  • 4.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION BY END-USER 2014-2023 ($ MILLION)
      • 4.4.5.1. HOSPITALS
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. APPLICATION
        • 4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.1.6. KEY CONCLUSIONS
      • 4.4.5.2. DIAGNOSTIC CENTERS
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. APPLICATION
        • 4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.2.6. KEY CONCLUSIONS
      • 4.4.5.3. RESEARCH CENTERS
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. APPLICATION
        • 4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.3.6. KEY CONCLUSIONS
  • 4.5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION BY APPLICATION 2014-2023 ($ MILLION)
      • 4.5.5.1. ORTHOPEDIC APPLICATIONS
        • 4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.1.3. APPLICATION
        • 4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.1.6. KEY CONCLUSIONS
      • 4.5.5.2. DENTAL APPLICATIONS
        • 4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.2.3. APPLICATION
        • 4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.2.6. KEY CONCLUSIONS
      • 4.5.5.3. NEUROLOGY
        • 4.5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.3.3. APPLICATION
        • 4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.3.6. KEY CONCLUSIONS
      • 4.5.5.4. CARDIOLOGY APPLICATIONS
        • 4.5.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.4.3. APPLICATION
        • 4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.4.6. KEY CONCLUSIONS
      • 4.5.5.5. ONCOLOGY APPLICATIONS
        • 4.5.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.5.3. APPLICATION
        • 4.5.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.5.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.5.6. KEY CONCLUSIONS
      • 4.5.5.6. OBSTETRICS AND GYNECOLOGY APPLICATIONS
        • 4.5.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.6.3. APPLICATION
        • 4.5.5.6.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.6.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.6.6. KEY CONCLUSIONS
      • 4.5.5.7. MAMMOGRAPHY APPLICATIONS
        • 4.5.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.7.3. APPLICATION
        • 4.5.5.7.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.7.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.7.6. KEY CONCLUSIONS
      • 4.5.5.8. UROLOGY AND NEPHROLOGY APPLICATIONS
        • 4.5.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.8.3. APPLICATION
        • 4.5.5.8.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.8.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.8.6. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. RUSSIA
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. . AGFA-GEVAERT GROUP
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION/FOCUS SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. AQUILAB
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION/FOCUS SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. BARCO
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION/FOCUS SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. BRUKER
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION/FOCUS SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. CARESTREAM HEALTH, INC.
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION/FOCUS SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. ELEKTA
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION/FOCUS SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. ESAOTE S.P.A
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION/FOCUS SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. GENERAL ELECTRIC COMPANY (GE)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION/FOCUS SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. INFIMED
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION/FOCUS SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. MERGE HEALTHCARE INC.
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION/FOCUS SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. MIM SOFTWARE, INC.
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION/FOCUS SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
  • 7.12. PHILIPS HEALTHCARE
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION/FOCUS SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. SIEMENS HEALTHCARE
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION/FOCUS SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. TOSHIBA MEDICAL SYSTEMS CORPORATION
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION/FOCUS SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. XINAPSE SYSTEMS LTD.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION/FOCUS SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE 2014-2023 ($ MILLION)
  • 2. GLOBAL INTEGRATED SOFTWARE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL STANDALONE SOFTWARE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE 2014-2023 ($ MILLION)
  • 5. GLOBAL 2D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL 3D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL 4D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY 2014-2023 ($ MILLION)
  • 9. GLOBAL TOMOGRAPHY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL ULTRASOUND IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL RADIOGRAPHIC IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL COMBINED MODALITIES BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END-USER 2014-2023 ($ MILLION)
  • 14. GLOBAL HOSPITALS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL DIAGONAL CENTERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. GLOBAL RESEARCH CENTERS BY GEOGRAPHY 2014-202 3($ MILLION)
  • 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 18. GLOBAL ORTHOPEDIC APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 19. GLOBAL DENTAL APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL NEUROLOGY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. GLOBAL CARDIOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 22. GLOBAL ONCOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 23. GLOBAL OBSTETRICS AND GYNECOLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 24. GLOBAL MAMMOGRAPHY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 25. GLOBAL UROLOGY AND NEPHROLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 26. NORTH AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 27. EUROPE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 28. ASIA PACIFIC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 29. REST OF THE WORLD MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS 2016-2023 ($ MILLION)
  • 2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS 2016-2023 ($ MILLION)
  • 3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS 2016-2023 ($ MILLION)
  • 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATION 2016-2023 ($ MILLION)
  • 5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATION 2016-2023 ($ MILLION)
  • 6. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY 2016-2023 ($ MILLION)
  • 7. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS 2016-2023 ($ MILLION)
  • 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATION 2016-2023 ($ MILLION)
  • 9. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS 2016-2023 ($ MILLION)
  • 10. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGONALS CENTERS 2016-2023 ($ MILLION)
  • 11. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS 2016-2023 ($ MILLION)
  • 12. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY 2016-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING 2016-2023 ($ MILLION)
  • 14. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING 2016-2023 ($ MILLION)
  • 15. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES 2016-2023 ($ MILLION)
  • 16. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D 2016-2023 ($ MILLION)
  • 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D 2016-2023 ($ MILLION)
  • 18. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 4D 2016-2023 ($ MILLION)
  • 19. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE 2016-2023 ($ MILLION)
  • 20. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE 2016-2023 ($ MILLION)
  • 21. UNITED STATES (U.S.) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 22. CANADA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 23. UNITED KINGDOM (UK) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 24. FRANCE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 25. GERMANY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 26. SPAIN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 27. ITALY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 28. ROE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 29. INDIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 30. CHINA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 31. JAPAN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 32. KOREA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 33. AUSTRALIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 34. ROAPAC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 35. LATIN AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 36. MENA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.